Kala Pharmaceuticals, Inc.
At Close: 4:00 PM
KALA Stock Price Graph
KALA Stock Price Today
Kala Pharmaceuticals, Inc. (KALA) stock declined over -2.82% intraday to trade at $7.24 a share on NASDAQ. The stock opened with a loss of -2.68% at $7.25 and touched an intraday high of $7.34, falling -2.82% against the last close of $7.45. The Kala Pharmaceuticals, Inc. in stock market went to a low of $6.81 during the session.
KALA Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
KALA Stock Price History Chart
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet derived growth factors for the treatment of retinal diseases, including wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion; and selective glucocorticoid receptor modulators program, a novel class of compounds to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.
Frequently Asked Questions
What is the current Kala Pharmaceuticals, Inc. (KALA) stock price?
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) stock price is $7.24 in the last trading session. During the trading session, KALA stock reached the peak price of $7.34 while $6.81 was the lowest point it dropped to. The percentage change in KALA stock occurred in the recent session was -2.82% while the dollar amount for the price change in KALA stock was -$0.21.
KALA's industry and sector of operation?
The NASDAQ listed KALA is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector. Kala Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases.
Who are the executives of KALA?
Mr. Eric L. Trachtenberg
Gen. Counsel, Chief Compliance Officer & Corporation Sec.
Mr. Vincent Kosewski
Senior Vice President of Manufacturing & Supply Chain Management
Ms. Michele LaRussa
Senior Vice President of Regulatory Affairs & Quality Assurance
Ms. Jill S. Steier
Executive Director of Investor Relations & Corporation Communications
How KALA did perform over past 52-week?
KALA's closing price is 3.29% higher than its 52-week low of $3.544 where as its distance from 52-week high of $56.72 is -0.73%.
How many employees does KALA have?
Number of KALA employees currently stands at N/A. KALA operates from 1167 Massachusetts Avenue, Arlington, MA 02476, US.
Link for KALA official website?
Official Website of KALA is: https://www.kalarx.com
How do I contact KALA?
How many shares of KALA are traded daily?
KALA stock volume for the day was 21168.00 shares. The average number of KALA shares traded daily for last 3 months was 64.79 Thousands.
What is the market cap of KALA currently?
The market value of KALA currently stands at $20.23 Million with its latest stock price at $7.24 and N/A of its shares outstanding.